{"id":503,"date":"2026-02-28T10:37:45","date_gmt":"2026-02-28T10:37:45","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/cabg-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T10:37:45","modified_gmt":"2026-02-28T10:37:45","slug":"cabg-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/cabg-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"CABG: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">CABG Introduction (What it is)<\/h2>\n\n\n\n<p>CABG stands for <strong>coronary artery bypass grafting<\/strong>.<br\/>\nIt is a <strong>surgical procedure<\/strong> used to improve blood flow to heart muscle affected by coronary artery disease.<br\/>\nCABG is commonly encountered in cardiology when evaluating <strong>multivessel coronary disease<\/strong>, <strong>left main disease<\/strong>, or symptoms not adequately controlled by other strategies.<br\/>\nIt is part of the broader field of <strong>coronary revascularization<\/strong>, alongside percutaneous coronary intervention (PCI).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why CABG matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>CABG is a cornerstone therapy in ischemic heart disease because it can restore myocardial perfusion when native coronary arteries have flow-limiting stenoses or occlusions. For learners, it connects core cardiology themes: coronary anatomy, myocardial oxygen supply\u2013demand balance, ischemia, infarction, and the practical decision-making involved in selecting a revascularization approach.<\/p>\n\n\n\n<p>Clinically, CABG often enters the conversation when coronary disease is extensive or anatomically complex. In many patients it is pursued to reduce ischemic symptoms (such as angina) and, in selected anatomic and clinical settings, to improve longer-term outcomes compared with alternative approaches. CABG is also a common \u201cteam sport\u201d in cardiovascular care, requiring integration of catheterization findings, echocardiography, perioperative medicine, anesthesia, and post-operative rehabilitation.<\/p>\n\n\n\n<p>From an education standpoint, CABG is a high-yield topic because it intersects with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Risk stratification:<\/strong> balancing operative risk against the expected benefit of revascularization.<\/li>\n<li><strong>Treatment planning:<\/strong> comparing medical therapy, PCI, and surgery in a patient-centered way.<\/li>\n<li><strong>Secondary prevention:<\/strong> emphasizing that revascularization treats flow limitation but does not \u201ccure\u201d atherosclerosis.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>CABG is a procedure rather than a disease, so \u201cclassification\u201d mainly refers to <strong>operative techniques<\/strong>, <strong>graft choices<\/strong>, and <strong>clinical context<\/strong>.<\/p>\n\n\n\n<p>Common variants include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>On-pump CABG (with cardiopulmonary bypass):<\/strong><\/li>\n<li>The heart is typically stopped and circulation is supported by a heart\u2013lung machine.<\/li>\n<li>Myocardial protection strategies are used to reduce ischemic injury during the operation.<\/li>\n<li>\n<p>Technique selection varies by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Off-pump CABG (beating-heart surgery):<\/strong><\/p>\n<\/li>\n<li>Grafts are constructed while the heart continues beating, using stabilization devices.<\/li>\n<li>\n<p>Often considered in selected patients; outcomes and adoption vary by center and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Graft conduit type:<\/strong><\/p>\n<\/li>\n<li><strong>Arterial grafts<\/strong> (commonly internal mammary artery, sometimes radial artery).<\/li>\n<li><strong>Venous grafts<\/strong> (commonly saphenous vein).<\/li>\n<li>\n<p>Conduit selection depends on anatomy, comorbidities, and surgeon preference.<\/p>\n<\/li>\n<li>\n<p><strong>Extent of revascularization:<\/strong><\/p>\n<\/li>\n<li>Single-vessel, multi-vessel, or \u201ccomplete\u201d revascularization (conceptually aiming to bypass all clinically important lesions).<\/li>\n<li>\n<p>\u201cCompleteness\u201d is individualized and may be limited by diffuse disease or small target vessels.<\/p>\n<\/li>\n<li>\n<p><strong>Approach and setting:<\/strong><\/p>\n<\/li>\n<li><strong>Isolated CABG<\/strong> versus <strong>combined procedures<\/strong> (e.g., CABG with valve surgery).<\/li>\n<li><strong>Elective<\/strong>, <strong>urgent<\/strong>, or <strong>emergent<\/strong> CABG depending on stability and anatomy.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding CABG starts with coronary circulation and myocardial perfusion.<\/p>\n\n\n\n<p><strong>Coronary anatomy (high level):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The <strong>left main coronary artery<\/strong> typically divides into:<\/li>\n<li><strong>Left anterior descending (LAD)<\/strong> artery, supplying anterior wall and septum.<\/li>\n<li><strong>Left circumflex (LCx)<\/strong> artery, supplying lateral\/posterolateral regions.<\/li>\n<li>The <strong>right coronary artery (RCA)<\/strong> often supplies the right ventricle and inferior wall; coronary dominance (right vs left) influences which vessel supplies the posterior descending artery.<\/li>\n<li>Proximal lesions (e.g., left main or proximal LAD) can jeopardize large territories of myocardium.<\/li>\n<\/ul>\n\n\n\n<p><strong>Physiology relevant to ischemia and revascularization:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Myocardial oxygen delivery depends on <strong>coronary blood flow<\/strong> and <strong>arterial oxygen content<\/strong>.<\/li>\n<li>Coronary perfusion occurs largely during <strong>diastole<\/strong>, especially in the left ventricle.<\/li>\n<li>Flow-limiting stenoses reduce the ability to increase coronary flow during stress, leading to <strong>ischemia<\/strong> and symptoms.<\/li>\n<\/ul>\n\n\n\n<p><strong>Surgical \u201cplumbing\u201d anatomy:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>CABG uses conduits to connect a high-pressure source (usually the <strong>ascending aorta<\/strong> or an in-situ arterial source) to a coronary artery <strong>beyond<\/strong> the obstructive lesion.<\/li>\n<li>Common conduits include:<\/li>\n<li><strong>Internal mammary artery (IMA):<\/strong> often left IMA to LAD due to favorable long-term patency in many series.<\/li>\n<li><strong>Saphenous vein graft (SVG):<\/strong> used for multiple targets; prone to atherosclerotic degeneration over time.<\/li>\n<li><strong>Radial artery:<\/strong> an arterial option with specific considerations (e.g., vasoreactivity, target selection).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>CABG treats the consequences of <strong>coronary atherosclerosis<\/strong>\u2014namely, reduced blood flow distal to a stenosis\u2014by creating a <strong>new route for blood to reach the myocardium<\/strong>.<\/p>\n\n\n\n<p>Mechanistically:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A conduit is attached proximally to an arterial inflow (often the aorta) or kept attached to its native origin (e.g., internal mammary artery as an in-situ graft).<\/li>\n<li>The distal end is sewn to a coronary artery segment <strong>downstream<\/strong> from the blockage.<\/li>\n<li>This bypass can restore perfusion to ischemic myocardium, improving oxygen delivery at rest and during exertion.<\/li>\n<\/ul>\n\n\n\n<p>Important physiologic concepts that influence CABG success:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Target vessel quality:<\/strong> severely diseased, small, or diffusely narrowed vessels can limit runoff and graft performance.<\/li>\n<li><strong>Competitive flow:<\/strong> if a native coronary lesion is not very flow limiting, substantial native flow may compete with graft flow, potentially affecting graft patency (the magnitude and clinical relevance vary by conduit and case).<\/li>\n<li><strong>Graft patency biology:<\/strong><\/li>\n<li>Venous grafts can develop intimal hyperplasia and later atherosclerosis.<\/li>\n<li>Arterial grafts may have better long-term durability in many contexts, but selection is individualized.<\/li>\n<\/ul>\n\n\n\n<p>When cardiopulmonary bypass is used, additional physiologic considerations include systemic inflammation, coagulation changes, and myocardial protection strategies. The exact intraoperative approach varies by protocol and patient factors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>CABG is typically considered in clinical scenarios such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Stable ischemic heart disease<\/strong> with:<\/li>\n<li>Extensive multivessel coronary artery disease on angiography.<\/li>\n<li>Anatomy that is complex or less amenable to PCI.<\/li>\n<li>\n<p>Persistent angina or ischemia despite optimized medical therapy (terminology and thresholds vary by clinician and case).<\/p>\n<\/li>\n<li>\n<p><strong>Left main coronary artery disease<\/strong> or equivalents involving large myocardial territories.<\/p>\n<\/li>\n<li>\n<p><strong>Diabetes mellitus with multivessel disease<\/strong>, where CABG is often discussed as part of comparative revascularization planning (the optimal choice depends on anatomy and patient factors).<\/p>\n<\/li>\n<li>\n<p><strong>Reduced left ventricular systolic function<\/strong> with significant coronary disease, when viability and ischemia considerations support revascularization.<\/p>\n<\/li>\n<li>\n<p><strong>Acute coronary syndromes<\/strong> (unstable angina or myocardial infarction) when:<\/p>\n<\/li>\n<li>Coronary anatomy is not suitable for PCI,<\/li>\n<li>There is ongoing ischemia or high-risk anatomy,<\/li>\n<li>\n<p>Or PCI has failed or is incomplete (timing is individualized).<\/p>\n<\/li>\n<li>\n<p><strong>Concomitant cardiac surgery<\/strong>, such as valve surgery, where bypassing significant coronary lesions during the same operation may be considered.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>CABG is not \u201cdiagnosed\u201d; rather, candidacy is assessed using a structured evaluation of coronary anatomy, myocardial function, and overall surgical risk.<\/p>\n\n\n\n<p>Common elements include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Coronary angiography (cardiac catheterization):<\/strong><\/li>\n<li>Defines the location, severity, and distribution of coronary stenoses.<\/li>\n<li>Helps determine target vessels, feasibility of grafting, and technical complexity.<\/li>\n<li>\n<p>Interpretation focuses on lesion location (e.g., left main, proximal LAD), diffuseness, calcification, chronic total occlusions, and distal vessel quality.<\/p>\n<\/li>\n<li>\n<p><strong>Noninvasive ischemia testing (selected patients):<\/strong><\/p>\n<\/li>\n<li>Stress ECG, stress echocardiography, nuclear perfusion imaging, or cardiac MRI may help demonstrate ischemia burden or viability, depending on the clinical scenario.<\/li>\n<li>\n<p>Testing choice varies by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Echocardiography:<\/strong><\/p>\n<\/li>\n<li>Assesses left ventricular ejection fraction, regional wall motion abnormalities, valvular disease, and pulmonary pressures.<\/li>\n<li>\n<p>Identifies conditions that may alter operative planning (e.g., significant valve disease).<\/p>\n<\/li>\n<li>\n<p><strong>Clinical and perioperative assessment:<\/strong><\/p>\n<\/li>\n<li>History and exam focusing on functional capacity, frailty, pulmonary disease, kidney disease, cerebrovascular disease, and bleeding risk.<\/li>\n<li>Baseline labs (renal function, hemoglobin, glucose control) to support risk estimation.<\/li>\n<li>\n<p>Additional testing (e.g., carotid evaluation) may be performed in selected patients; practices vary by center.<\/p>\n<\/li>\n<li>\n<p><strong>Shared decision-making framework:<\/strong><\/p>\n<\/li>\n<li>Many institutions use a \u201cheart team\u201d approach (cardiologist, cardiac surgeon, and others) to integrate anatomy, symptoms, comorbidities, and patient goals.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>CABG fits into the broader management of coronary artery disease, which typically includes <strong>risk factor control<\/strong>, <strong>anti-ischemic therapy<\/strong>, and <strong>revascularization<\/strong> when appropriate.<\/p>\n\n\n\n<p>A high-level pathway often looks like this:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Foundational management (across most CAD patients):<\/strong><\/li>\n<li>Lifestyle and risk factor modification (smoking cessation, activity, nutrition, weight management).<\/li>\n<li>Lipid-lowering therapy, blood pressure management, and diabetes management as indicated.<\/li>\n<li>Antianginal and cardioprotective medications as clinically appropriate.<\/li>\n<li>\n<p>These strategies remain important before and after CABG because atherosclerosis is systemic.<\/p>\n<\/li>\n<li>\n<p><strong>Choosing a revascularization strategy:<\/strong><\/p>\n<\/li>\n<li><strong>Medical therapy alone<\/strong> may be reasonable in some stable presentations with manageable symptoms and lower-risk anatomy.<\/li>\n<li><strong>PCI<\/strong> may be favored for focal lesions, certain acute coronary syndromes, or when surgical risk is high.<\/li>\n<li><strong>CABG<\/strong> is often considered for complex multivessel disease, left main disease, or when durable revascularization is desired and anatomy is suitable.<\/li>\n<li>\n<p>The \u201cbest\u201d option is not universal; it varies by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Perioperative CABG care (conceptual components):<\/strong><\/p>\n<\/li>\n<li>Preoperative optimization of comorbidities and medication reconciliation (e.g., antiplatelet strategy is individualized).<\/li>\n<li>Intraoperative decisions about conduits, number of grafts, and use of cardiopulmonary bypass.<\/li>\n<li>\n<p>Post-operative care: pain control, pulmonary hygiene, rhythm monitoring, glycemic management, and early mobilization per institutional pathways.<\/p>\n<\/li>\n<li>\n<p><strong>Post-CABG secondary prevention and recovery:<\/strong><\/p>\n<\/li>\n<li>Long-term antithrombotic, lipid-lowering, and anti-ischemic strategies are commonly used; specific regimens vary by patient factors and protocols.<\/li>\n<li><strong>Cardiac rehabilitation<\/strong> is frequently recommended to support safe, graded return to activity and risk reduction education.<\/li>\n<li>Follow-up includes symptom surveillance and management of cardiovascular risk factors.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>CABG is major surgery, and risks depend on age, comorbidities, coronary anatomy, urgency, and institutional experience. Commonly discussed complications and limitations include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Perioperative myocardial injury or infarction<\/strong><\/li>\n<li><strong>Stroke or transient neurologic events<\/strong><\/li>\n<li><strong>Bleeding<\/strong>, transfusion needs, or re-exploration for bleeding<\/li>\n<li><strong>Infection<\/strong>, including superficial wound infection and (less commonly) deep sternal wound infection<\/li>\n<li><strong>Post-operative atrial fibrillation<\/strong> and other arrhythmias<\/li>\n<li><strong>Acute kidney injury<\/strong><\/li>\n<li><strong>Respiratory complications<\/strong>, such as atelectasis or pneumonia<\/li>\n<li><strong>Pleural effusions<\/strong> or pericardial effusion<\/li>\n<li><strong>Neurocognitive changes<\/strong> reported by some patients after surgery (severity and duration vary)<\/li>\n<li><strong>Graft failure or occlusion<\/strong>, which can present as recurrent angina or acute coronary syndromes<\/li>\n<li><strong>Limitations of revascularization:<\/strong><\/li>\n<li>CABG does not remove atherosclerosis; progression in native vessels and grafts can occur.<\/li>\n<li>Some patients have diffuse distal disease or poor target vessels that limit complete revascularization.<\/li>\n<li>Repeat revascularization (PCI or redo surgery) may be needed in some cases over time.<\/li>\n<\/ul>\n\n\n\n<p>Contraindications are not absolute in a single list because suitability is individualized; factors like severe frailty, limited life expectancy from non-cardiac disease, or prohibitive surgical risk may shift decisions toward other approaches.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Outcomes after CABG vary widely by clinical presentation and patient factors. In general, many patients experience improvement in angina and functional capacity when grafts remain patent and comorbidities are well managed. Prognosis is influenced by:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Coronary anatomy and completeness of revascularization<\/strong> achievable<\/li>\n<li><strong>Left ventricular function<\/strong> and extent of prior myocardial infarction or scar<\/li>\n<li><strong>Conduit choice and graft patency over time<\/strong><\/li>\n<li><strong>Comorbidities<\/strong> (diabetes, chronic kidney disease, peripheral arterial disease, lung disease)<\/li>\n<li><strong>Adherence to secondary prevention<\/strong> strategies and participation in rehabilitation<\/li>\n<li><strong>Post-operative complications<\/strong>, which can affect short- and long-term recovery<\/li>\n<\/ul>\n\n\n\n<p>Follow-up commonly includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Clinical review of symptoms (angina, dyspnea), blood pressure, and medication tolerance<\/li>\n<li>Wound and sternum healing assessment early after surgery<\/li>\n<li>Rhythm evaluation if palpitations or post-operative atrial fibrillation occurred<\/li>\n<li>Ongoing risk factor management and reinforcement of lifestyle measures<\/li>\n<li>Further testing if symptoms recur or functional status declines (test selection varies by clinician and case)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">CABG Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does CABG stand for, in plain language?<\/strong><br\/>\nCABG stands for coronary artery bypass grafting. It is an operation that creates a new route for blood to flow around blocked heart arteries. The goal is to improve blood supply to the heart muscle beyond the blockage.<\/p>\n\n\n\n<p><strong>Q: Is CABG the same as \u201copen-heart surgery\u201d?<\/strong><br\/>\nCABG is often performed via a median sternotomy (opening the breastbone), and many people refer to this as open-heart surgery. Some CABG operations use a heart\u2013lung machine (on-pump), while others are done on a beating heart (off-pump). The exact approach depends on patient factors and surgical planning.<\/p>\n\n\n\n<p><strong>Q: How is CABG different from a stent (PCI)?<\/strong><br\/>\nPCI typically uses a catheter-based approach to open a narrowed artery from within, often placing a stent to keep it open. CABG creates a bypass channel to deliver blood past the narrowed segment. Which strategy is favored depends on coronary anatomy, clinical context, and individualized risk\u2013benefit assessment.<\/p>\n\n\n\n<p><strong>Q: Where do bypass grafts come from?<\/strong><br\/>\nCommon graft sources include the internal mammary artery from the chest wall, the radial artery from the forearm, and the saphenous vein from the leg. Arterial and venous conduits behave differently over time, and selection is individualized. Surgeons choose grafts based on target vessels, patient comorbidities, and operative goals.<\/p>\n\n\n\n<p><strong>Q: What are common reasons a cardiology team recommends CABG?<\/strong><br\/>\nCABG is commonly discussed for left main disease, multivessel coronary disease, or anatomy that is complex for PCI. It may also be considered when symptoms persist despite medical therapy or when another cardiac surgery is planned and significant coronary disease is present. The decision is often made using a heart team approach.<\/p>\n\n\n\n<p><strong>Q: What is recovery like after CABG?<\/strong><br\/>\nRecovery typically includes a hospital stay followed by gradual improvement in energy, pain control, and physical capacity. Many patients participate in cardiac rehabilitation to support a structured return to activity and education about risk reduction. The pace of recovery varies by patient factors, complications, and baseline fitness.<\/p>\n\n\n\n<p><strong>Q: When can someone return to normal activities or work after CABG?<\/strong><br\/>\nReturn to activities depends on healing (including the sternum if a sternotomy was performed), functional recovery, and job demands. Light activities are often reintroduced earlier than heavy lifting or physically demanding work. Specific timelines vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: Will a person still need heart medications after CABG?<\/strong><br\/>\nMany patients continue medications after CABG to reduce future cardiovascular risk and protect grafts and native arteries. These commonly include lipid-lowering therapy and other agents based on blood pressure, symptoms, rhythm, and comorbidities. The exact regimen varies by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: Can coronary disease come back after CABG?<\/strong><br\/>\nCABG improves blood flow past existing blockages but does not eliminate the underlying atherosclerosis process. Over time, native coronary disease can progress and grafts can narrow or occlude. Ongoing secondary prevention and follow-up are central to long-term management.<\/p>\n\n\n\n<p><strong>Q: How do clinicians monitor patients after CABG?<\/strong><br\/>\nFollow-up generally focuses on symptoms, physical function, medication tolerance, and risk factor control. Testing is often guided by clinical changes, such as recurrent chest discomfort or reduced exercise capacity. Routine imaging schedules vary by clinician and case.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CABG stands for **coronary artery bypass grafting**. It is a **surgical procedure** used to improve blood flow to heart muscle affected by coronary artery disease. CABG is commonly encountered in cardiology when evaluating **multivessel coronary disease**, **left main disease**, or symptoms not adequately controlled by other strategies. It is part of the broader field of **coronary revascularization**, alongside percutaneous coronary intervention (PCI).<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-503","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=503"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/503\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}